Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

…, C Buracchi, P Bonaccorso, E Oliveira… - Blood, The Journal …, 2017 - ashpublications.org
A fully-standardized EuroFlow 8–color antibody panel and laboratory procedure was stepwise
designed to measure minimal residual disease (MRD) in B-cell precursor (BCP) acute …

[HTML][HTML] Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer

…, V Botafogo, M Fontana, LS Thiago, E Oliveira… - PLoS …, 2013 - journals.plos.org
Pediatric cancer is a relatively rare and heterogeneous group of hematological and non-hematological
malignancies which require multiple procedures for its diagnostic screening and …

Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B …

…, G Gaipa, A Sonsala, M Twardoch, E Oliveira… - Journal of …, 2019 - Elsevier
Background Optimal discrimination between leukemic blasts and normal B-cell precursors (BCP)
is critical for treatment monitoring in BCP acute lymphoblastic leukemia (ALL); thus …

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies—a EuroFlow …

…, M Szczepanowski, J Kulis, E Oliveira… - British Journal of …, 2022 - Wiley Online Library
The standardized EuroFlow protocol, including CD19 as primary B‐cell marker, enables
highly sensitive and reliable minimal residual disease (MRD) assessment in B‐cell precursor …

[HTML][HTML] Flow cytometry immunophenotyping for diagnostic orientation and classification of pediatric cancer based on the EuroFlow Solid Tumor Orientation Tube …

…, S Romano, DV Lopes, LC Teixeira, E Oliveira… - Cancers, 2021 - mdpi.com
Simple Summary Pediatric solid tumors are a heterogenous group of diseases that comprise
≈ 40% of all pediatric cancers, early diagnosis being key for improved survival. Here we …

[HTML][HTML] Bone marrow stromal cell regeneration profile in treated B-cell precursor acute lymphoblastic leukemia patients: association with MRD status and patient …

E Oliveira, ES Costa, J Ciudad, G Gaipa, Ł Sedek… - Cancers, 2022 - mdpi.com
Simple Summary For the last 20 years, measurable residual disease (MRD) has proven to
be a strong prognostic factor in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). …

Excoriation disorder: Impulsivity and its clinical associations

ECB Oliveira, EW Leppink, KL Derbyshire… - Journal of Anxiety …, 2015 - Elsevier
Excoriation disorder is the repetitive scratching or picking of skin that leads to physical
damage, distress, and functional impairment. Skin picking has been associated with impulsivity …

Minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukemia by semi‐automated identification of normal hematopoietic cells: A EuroFlow …

…, M Buysse, M Reiterová, E Oliveira… - Cytometry Part B …, 2023 - Wiley Online Library
Presence of minimal residual disease (MRD), detected by flow cytometry, is an important
prognostic biomarker in the management of B‐cell precursor acute lymphoblastic leukemia (…

[HTML][HTML] Altered neutrophil immunophenotypes in childhood B-cell precursor acute lymphoblastic leukemia

E Oliveira, TS Bacelar, J Ciudad, MCM Ribeiro… - Oncotarget, 2016 - ncbi.nlm.nih.gov
An increasing number of evidences suggest a genetic predisposition in acute lymphoblastic
leukemia (ALL) that might favor the occurrence of the driver genetic alterations. Such …

[HTML][HTML] Oat bran in cardiovascular risk control in mental disorder

ECD Oliveira, GC Barbosa, JE Corrente… - Revista Brasileira de …, 2020 - SciELO Brasil
Objective: To evaluate the effect of oat bran supplementation on cardiovascular risk components
of patients with mental disorders. Method: A before-and-after study, no control group. …